Medication-Assisted Treatment for Alcohol and Opioid Addiction: A Patient and Family Guide

South Asian man struggling with drinking

Medication-Assisted Treatment (MAT) refers to using medication as part of treatment for a substance use disorder. Clinicians increasingly use terms such as medications for opioid use disorder and medications for alcohol use disorder because medication is not simply an optional addition to counseling. For some addictions, it is a central part of evidence-based treatment.

This can be difficult for families who expect recovery to mean stopping all substances and medications associated with addiction. A patient enters treatment to stop using opioids or alcohol, and then a physician recommends another medication. That can sound contradictory until the purpose of the medication is understood.

“Aren’t You Just Replacing One Drug With Another?”

This is one of the most common concerns about medications for opioid addiction.

Methadone and buprenorphine act on opioid receptors, but taking a prescribed medication at a controlled dose is very different from compulsively using fentanyl, heroin, or prescription opioids.

Buprenorphine and methadone can reduce withdrawal and cravings and help interrupt the cycle of intoxication, withdrawal, drug-seeking, and relapse. Naltrexone works differently by blocking opioid receptors. All three are approved in the U.S. for opioid use disorder.

The relevant question is not simply whether a medication affects opioid receptors. It is whether treatment reduces illicit opioid use, overdose risk, withdrawal, cravings, and the instability caused by addiction.

South Asian Families May Prefer the Idea of “Detox and Done”

Some families expect treatment to follow a simple sequence: the patient goes away, detoxes, comes home sober, and never needs another addiction-related medication.

That approach can be appealing because it fits ideas about discipline, abstinence, and putting the problem completely behind the family. Opioid addiction often does not work that way.

A patient can complete withdrawal and still have strong cravings, reduced opioid tolerance, and substantial risk of relapse. Returning to opioids after a period of abstinence can also increase overdose risk.

For some patients, remaining on medication for months or years is safer than repeatedly cycling through abstinence, relapse, and detoxification. Treatment should be judged by whether it supports sustained recovery, not by how quickly every medication can be stopped.

The Three Main Medications for Opioid Use Disorder

Buprenorphine

Buprenorphine reduces opioid withdrawal and cravings. It has a ceiling effect on some of its opioid activity, which gives it a different safety profile from full opioid agonists. It is often combined with naloxone in products such as Suboxone.

A major practical advantage is that buprenorphine can be prescribed outside an opioid treatment program. The previous federal requirement for clinicians to obtain a special waiver to prescribe it was eliminated in 2023.

For many patients, buprenorphine makes it possible to work, sleep, care for family, and function without spending the day managing withdrawal or seeking opioids.

Methadone

Methadone is a full opioid agonist with decades of evidence supporting its use for opioid use disorder. In the U.S., it is generally provided for opioid addiction through federally certified opioid treatment programs.

It may be particularly useful for patients with substantial opioid tolerance or when other approaches have not worked adequately.

Methadone can carry considerable stigma because families may associate the medication, treatment clinic, or daily dosing with ongoing addiction. The medication should instead be evaluated by whether it reduces illicit opioid use, withdrawal, cravings, and other harms.

Naltrexone

Naltrexone is not an opioid agonist. It blocks opioid receptors and prevents opioids from producing their usual effects. It is available as an oral medication and as a long-acting injection.

Patients must be sufficiently free of opioids before starting naltrexone because beginning it too soon can precipitate withdrawal.

For patients who prefer a medication that does not activate opioid receptors and who can complete the required opioid-free period, naltrexone may be an appropriate option.

Medication Can Treat Alcohol Addiction Too

Medication treatment is not limited to opioids. Three medications are approved by the U.S. Food and Drug Administration (FDA) for alcohol use disorder: naltrexone, acamprosate, and disulfiram.

Naltrexone

Naltrexone can reduce the rewarding effects of alcohol, cravings, and heavy drinking. It may be useful for someone who repeatedly intends to have one or two drinks but has difficulty stopping once drinking begins.

Acamprosate

Acamprosate is generally used after alcohol has been stopped and can help support continued abstinence. It does not treat acute withdrawal and does not make someone sick if they drink.

Disulfiram

Disulfiram causes an unpleasant physical reaction if alcohol is consumed while taking it. For carefully selected patients who understand and reliably take the medication, that consequence can provide an additional barrier against drinking.

It is not appropriate for every patient and requires good adherence and understanding of the risks.

Medication Does Not Replace the Rest of Treatment

Medication can reduce biological pressure to return to alcohol or opioids, but it does not automatically resolve the circumstances surrounding the addiction.

Someone taking naltrexone may still need to change a social routine built around drinking every weekend. A patient taking buprenorphine may still need treatment for depression, trauma, or anxiety. Someone receiving methadone may need to repair relationships, change drug-using social contacts, manage money differently, and rebuild trust.

Medication can make those changes more achievable by reducing cravings, withdrawal, and repeated intoxication.

Families Can Undermine Treatment Without Meaning To

Family pressure to stop medication can interfere with recovery.

A patient may return home taking buprenorphine and repeatedly hear, “When are you getting off that?” Relatives may treat every dose reduction as progress and continued medication as evidence that recovery is incomplete.

That pressure can lead someone to taper before they are clinically ready.

This can be particularly relevant in families where relatives are heavily involved in medical decisions and where sobriety is understood as being completely free from any medication related to addiction.

A more useful question is: “Is this medication helping you remain stable and recover?”

The goal should not automatically be to become medication-free as quickly as possible.

Taking Medication Every Day Is Not the Same as Addiction

Physical dependence and addiction are not the same thing.

Addiction involves patterns such as compulsive use, loss of control, continued use despite harm, and persistent pursuit of a substance for its reinforcing effects. Physical dependence can occur with many medications taken appropriately.

A person taking a stable prescribed dose of buprenorphine every morning, working, caring for family, and no longer compulsively seeking fentanyl is in a substantially different situation from someone repeatedly using illicit opioids throughout the day.

Daily medication use by itself does not mean an addiction is continuing. It may mean the disorder is being treated.

Medication Does Not Have to Be Lifelong

Starting medication does not automatically mean taking it forever.

Some patients remain on medication for extended periods because they continue to benefit. Others taper after sustained stability. The timing should depend on the patient’s clinical situation rather than embarrassment, family pressure, or a predetermined deadline.

Medication also has to fit realistically into the patient’s life. Access, dosing requirements, work schedules, transportation, cost, and availability can all influence which treatment is practical.

Medication Remains Underused

Despite evidence supporting these medications, many people with alcohol or opioid use disorder do not receive them.

Some patients are never told medication is an option. Others decline it because of stigma or misconceptions. Some treatment programs may also place unnecessary barriers around medication use.

An addiction treatment program should evaluate whether medication could help rather than rejecting it because of a particular philosophy about what recovery should look like.

Medication-Assisted Treatment at South Asian Recovery Center

South Asian Recovery Center is a physician-owned and managed residential substance use treatment facility in Los Angeles designed for South Asian individuals and families. Treatment includes medical evaluation and management, including Medication-Assisted Treatment when appropriate, along with individual and group counseling, family involvement when desired, case management, and continuing-care planning.

Family education can be particularly important. A parent may need to understand why prescribed buprenorphine is different from continued fentanyl use. A spouse may need reassurance that naltrexone is not addictive. A patient may need help separating appropriate medication treatment from the belief that needing medication reflects inadequate willpower.

Culture does not determine which medication is medically appropriate, but family beliefs and stigma can strongly affect whether a patient is willing to take it consistently.

If alcohol or opioid addiction has been difficult to control, contact South Asian Recovery Center (SARC) to discuss a medical assessment and whether medication should be part of the treatment plan.